Filing Details

Accession Number:
0001104659-25-041622
Form Type:
13D Filing
Publication Date:
2025-04-28 20:00:00
Filed By:
Alliance Sante Participations S.A.
Company:
Walgreens Boots Alliance Inc. (NASDAQ:WBA)
Filing Date:
2025-04-29
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Alliance Sante Participations S.A. 0 0 0 0 0 0%
NewCIP II S.a r.l. 0 0 0 0 0 0%
Alliance Sante Participations Ltd. 145,621,079 0 145,621,079 0 145,621,079 16.8%
Stefano Pessina 147,615,089 0 147,615,089 0 147,615,089 17.1%
Filing





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D



Comment for Type of Reporting Person:
The calculation in line 13 is based on 864,737,898 shares of Common Stock, par value $0.01 per share, outstanding as of April 1, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q for the period ended February 28, 2025 filed with the Securities and Exchange Commission on April 8, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
The calculation in line 13 is based on 864,737,898 shares of Common Stock, par value $0.01 per share, outstanding as of April 1, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q for the period ended February 28, 2025 filed with the Securities and Exchange Commission on April 8, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
The calculation in line 13 is based on 864,737,898 shares of Common Stock, par value $0.01 per share, outstanding as of April 1, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q for the period ended February 28, 2025 filed with the Securities and Exchange Commission on April 8, 2025.


SCHEDULE 13D



Comment for Type of Reporting Person:
The calculation in line 13 is based on 864,737,898 shares of Common Stock, par value $0.01 per share, outstanding as of April 1, 2025, as reported by the Issuer in its Quarterly Report on Form 10-Q for the period ended February 28, 2025 filed with the Securities and Exchange Commission on April 8, 2025.


SCHEDULE 13D

 
Alliance Sante Participations S.A.
 
Signature:/s/ Simone Retter
Name/Title:Simone Retter/President (Chairman)
Date:04/29/2025
 
Signature:/s/ Stefano Pessina
Name/Title:Stefano Pessina/Administrateur (Director)
Date:04/29/2025
 
NewCIP II S.a r.l.
 
Signature:/s/ Simone Retter
Name/Title:Simone Retter/Gerant (Manager)
Date:04/29/2025
 
Signature:/s/ Stefano Pessina
Name/Title:Stefano Pessina/Gerant (Manager)
Date:04/29/2025
 
Alliance Sante Participations Ltd.
 
Signature:/s/ Stefano Pessina
Name/Title:Stefano Pessina/Director
Date:04/29/2025
 
Signature:/s/ Ben Burman
Name/Title:Ben Burman/Director
Date:04/29/2025
 
Stefano Pessina
 
Signature:/s/ Stefano Pessina
Name/Title:Stefano Pessina
Date:04/29/2025